Journal of Periodontal and Implant Science

Korean Academy of Periodontology (대한치주과학회)
권호 표지
DOI QR코드

DOI QR Code

Effects of immunosuppressants, FK506 and cyclosporin A, on the osteogenic differentiation of rat mesenchymal stem cells

  • Byun, Yu-Kyung (Department of Periodontology, Dental Research Institute, Seoul National University School of Dentistry) ;
  • Kim, Kyoung-Hwa (Department of Periodontology, Dental Research Institute, Seoul National University School of Dentistry) ;
  • Kim, Su-Hwan (Department of Periodontics, Asan Medical Center) ;
  • Kim, Young-Sung (Department of Periodontics, Asan Medical Center) ;
  • Koo, Ki-Tae (Department of Periodontology, Dental Research Institute, Seoul National University School of Dentistry) ;
  • Kim, Tai-Il (Department of Periodontology, Dental Research Institute, Seoul National University School of Dentistry) ;
  • Seol, Yang-Jo (Department of Periodontology, Dental Research Institute, Seoul National University School of Dentistry) ;
  • Ku, Young (Department of Periodontology, Dental Research Institute, Seoul National University School of Dentistry) ;
  • Rhyu, In-Chul (Department of Periodontology, Dental Research Institute, Seoul National University School of Dentistry) ;
  • Lee, Yong-Moo (Department of Periodontology, Dental Research Institute, Seoul National University School of Dentistry)
  • Received : 2011.12.29
  • Accepted : 2012.04.24
  • Published : 2012.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The purpose of this study was to investigate the effects of the immunosuppressants FK506 and cyclosporin A (CsA) on the osteogenic differentiation of rat mesenchymal stem cells (MSCs). Methods: The effect of FK506 and CsA on rat MSCs was assessed in vitro. The MTT assay was used to determine the deleterious effect of immunosuppressants on stem cell proliferation at 1, 3, and 7 days. Alkaline phosphatase (ALP) activity was analyzed on days 3, 7, and 14. Alizarin red S staining was done on day 21 to check mineralization nodule formation. Real-time polymerase chain reaction (RT-PCR) was also performed to detect the expressions of bone tissue-specific genes on days 1 and 7. Results: Cell proliferation was promoted more in the FK506 groups than the control or CsA groups on days 3 and 7. The FK506 groups showed increased ALP activity compared to the other groups during the experimental period. The ALP activity of the CsA groups did not differ from the control group in any of the assessments. Mineralization nodule formation was most prominent in the FK506 groups at 21 days. RT-PCR results of the FK506 groups showed that several bone-related genes-osteopontin, osteonectin, and type I collagen (Col-I)-were expressed more than the control in the beginning, but the intensity of expression decreased over time. Runx2 and Dlx5 gene expression were up-regulated on day 7. The effects of 50 nM CsA on osteonectin and Col-I were similar to those of the FK506 groups, but in the 500 nM CsA group, most of the genes were less expressed compared to the control. Conclusions: These results suggest that FK506 enhances the osteoblastic differentiation of rat MSCs. Therefore, FK506 might have a beneficial effect on bone regeneration when immunosuppressants are needed in xenogenic or allogenic stem cell transplantation to treat bone defects.

Keywords

References

  1. Otto WR, Wright NA. Mesenchymal stem cells: from experiment to clinic. Fibrogenesis Tissue Repair 2011;4:20.
  2. Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007; 213:341-7.
  3. Nauta AJ, Westerhuis G, Kruisselbrink AB, Lurvink EG, Willemze R, Fibbe WE. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood 2006;108:2114-20.
  4. Penninga L, Moller CH, Gustafsson F, Steinbruchel DA, Gluud C. Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials. Eur J Clin Pharmacol 2010;66:1177-87.
  5. Vincenti F, Jensik SC, Filo RS, Miller J, Pirsch J. A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. Transplantation 2002;73:775-82.
  6. Epstein S. Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton. J Bone Miner Res 1996;11:1-7.
  7. Kino T, Hatanaka H, Hashimoto M, Nishiyama M, Goto T, Okuhara M, et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot (Tokyo) 1987;40:1249-55.
  8. Kino T, Hatanaka H, Miyata S, Inamura N, Nishiyama M, Yajima T, et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot (Tokyo) 1987;40:1256-65.
  9. Kulak CA, Borba VZ, Kulak Junior J, Campos DJ, Shane E. Post-transplantation osteoporosis. Arq Bras Endocrinol Metabol 2010;54:143-9.
  10. Rodino MA, Shane E. Osteoporosis after organ transplantation. Am J Med 1998;104:459-69.
  11. Stein E, Ebeling P, Shane E. Post-transplantation osteoporosis. Endocrinol Metab Clin North Am 2007;36:937-63; viii.
  12. Cvetkovic M, Mann GN, Romero DF, Liang XG, Ma Y, Jee WS, et al. The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo. Transplantation 1994;57:1231-7.
  13. Fukunaga J, Yamaai T, Yamachika E, Ishiwari Y, Tsujigiwa H, Sawaki K, et al. Expression of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in rat osteoporosis induced by immunosuppressant FK506. Bone 2004;34:425-31.
  14. Krocker D, Perka C, Tuischer J, Funk J, Tohtz S, Buttgereit F, et al. Effects of tacrolimus, cyclosporin A and sirolimus on MG63 cells. Transpl Int 2006;19:563-9.
  15. Lee KW, Yook JY, Son MY, Kim MJ, Koo DB, Han YM, et al. Rapamycin promotes the osteoblastic differentiation of human embryonic stem cells by blocking the mTOR pathway and stimulating the BMP/Smad pathway. Stem Cells Dev 2010;19:557-68.
  16. Isomoto S, Hattori K, Ohgushi H, Nakajima H, Tanaka Y, Takakura Y. Rapamycin as an inhibitor of osteogenic differentiation in bone marrow-derived mesenchymal stem cells. J Orthop Sci 2007;12:83-8.
  17. Kaihara S, Bessho K, Okubo Y, Sonobe J, Kawai M, Iizuka T. Simple and effective osteoinductive gene therapy by local injection of a bone morphogenetic protein-2-expressing recombinant adenoviral vector and FK506 mixture in rats. Gene Ther 2004;11:439-47.
  18. Yoshikawa T, Nakajima H, Yamada E, Akahane M, Dohi Y, Ohgushi H, et al. In vivo osteogenic capability of cultured allogeneic bone in porous hydroxyapatite: immunosuppressive and osteogenic potential of FK506 in vivo. J Bone Miner Res 2000;15:1147-57.
  19. Kugimiya F, Yano F, Ohba S, Igawa K, Nakamura K, Kawaguchi H, et al. Mechanism of osteogenic induction by FK506 via BMP/Smad pathways. Biochem Biophys Res Commun 2005;338:872-9.
  20. Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991;66: 807-15.
  21. Tang L, Ebara S, Kawasaki S, Wakabayashi S, Nikaido T, Takaoka K. FK506 enhanced osteoblastic differentiation in mesenchymal cells. Cell Biol Int 2002;26:75-84.
  22. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, et al. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 1990;143:420-30.
  23. Shin JH, Kim KH, Kim SH, Koo KT, Kim TI, Seol YJ, et al. Ex vivo bone morphogenetic protein-2 gene delivery using gingival fibroblasts promotes bone regeneration in rats. J Clin Periodontol 2010;37:305-11.

Cited by

  1. Potential differentiation ability of gingiva originated human mesenchymal stem cell in the presence of tacrolimus vol.6, pp.None, 2016, https://doi.org/10.1038/srep34910
  2. Effects of tacrolimus on morphology, proliferation and differentiation of mesenchymal stem cells derived from gingiva tissue vol.14, pp.1, 2016, https://doi.org/10.3892/mmr.2016.5217
  3. MicroRNA expression analysis during FK506-induced osteogenic differentiation in rat bone marrow stromal cells vol.16, pp.1, 2012, https://doi.org/10.3892/mmr.2017.6655
  4. FK506 Induces Ligand-Independent Activation of the Bone Morphogenetic Protein Pathway and Osteogenesis vol.20, pp.8, 2012, https://doi.org/10.3390/ijms20081900
  5. Proliferation and osteogenic differentiation of bone marrow-derived mesenchymal stem cell after exposure to red flesh dragon fruit extract vol.17, pp.2, 2012, https://doi.org/10.4103/1735-3327.280885
  6. Cyclosporin A Enhances Cardiac Differentiation by Inhibiting Wnt/β-Catenin Signaling in Human Embryonic Stem Cells vol.26, pp.5, 2012, https://doi.org/10.1007/s12257-020-0296-y